Skip to main content
Premium Trial:

Request an Annual Quote

Genalyte, Scienion Ink Marketing Pact

NEW YORK (GenomeWeb News) – Multiplex assay developer Genalyte said today that it will market Scienion's automated liquid dispensers with its Maverick Detection System.

Under the agreement, San Diego-based Genalyte will market Scienion's Sciflexarrayers, automated non-contact dispensing systems for ultra-low volume liquid handling of biological samples, alongside the Maverick, which uses a silicon chip containing photonic microring sensor arrays. The arrays simultaneously analyze proteins, DNA, or biomarkers from small samples using a one-step process that includes the washes, incubations, and reagent and processing steps.

The Maverick system can provide results from small samples from serum, plasma, culture media, and whole blood, the firms added.

Under the alliance, Berlin-based Scienion retains responsibility for installing and servicing the Sciflexarrayers that Genalyte sells.

Genalyte also today launched its Custom Spotting Service. The company will load proteins such as antibodies, peptides, biomarkers, cytokines, and antigens that are provided by customers and then return them in a ready-to-use chip assay format that runs on the Maverick.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.